Pfizer (U.K. Rights to 3 Products)
M&A
STATUS
Asset Purch.
LATEST DEAL TYPE
1
FINANCING ROUNDS
Description
Portfolio of dermatology products. The portfolio consists of the following brands, the oral antihistamine Atarax, the oral steroid Deltacortril, and Terracortril, a topical combination steroid.
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- England, United Kingdom
Pfizer (U.K. Rights to 3 Products) Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Pfizer (U.K. Rights to 3 Products)‘s full profile, request access.
Request full access to PitchBookPfizer (U.K. Rights to 3 Products) Former Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Pfizer (U.K. Rights to 3 Products)‘s full profile, request access.
Request full access to PitchBook